Peter S. Hammerman

2003–2021 年に発表

80
論文数
40,055
被引用数
74
h 指数
80
i10 指数

被引用数

Peter S. Hammerman の年別被引用数1976 年: 被引用 2 件1980 年: 被引用 1 件1995 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 1 件2003 年: 被引用 3 件2004 年: 被引用 35 件2005 年: 被引用 52 件2006 年: 被引用 60 件2007 年: 被引用 66 件2008 年: 被引用 62 件2009 年: 被引用 73 件2010 年: 被引用 71 件2011 年: 被引用 77 件2012 年: 被引用 108 件2013 年: 被引用 342 件2014 年: 被引用 503 件2015 年: 被引用 767 件2016 年: 被引用 893 件2017 年: 被引用 931 件2018 年: 被引用 953 件2019 年: 被引用 2,255 件2020 年: 被引用 2,570 件2021 年: 被引用 2,293 件2022 年: 被引用 1,687 件2023 年: 被引用 1,140 件2024 年: 被引用 1,497 件2025 年: 被引用 696 件2026 年: 被引用 30 件1977〜1979 年は被引用が無いため表示していません1981〜1994 年は被引用が無いため表示していません1996〜1997 年は被引用が無いため表示していません2001〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,448 件、この内訳の 28.6%中国: 引用元論文 3,759 件、この内訳の 16.7%イギリス: 引用元論文 1,160 件、この内訳の 5.2%ドイツ: 引用元論文 1,033 件、この内訳の 4.6%イタリア: 引用元論文 897 件、この内訳の 4%日本: 引用元論文 865 件、この内訳の 3.8%フランス: 引用元論文 718 件、この内訳の 3.2%カナダ: 引用元論文 678 件、この内訳の 3%スペイン: 引用元論文 634 件、この内訳の 2.8%韓国: 引用元論文 502 件、この内訳の 2.2%オーストラリア: 引用元論文 462 件、この内訳の 2.1%オランダ: 引用元論文 430 件、この内訳の 1.9%
0%28.6%その他 21.9%

分野

  • Medicine48.9%
  • Biochemistry, Genetics and Molecular Biology41%
  • Immunology and Microbiology6.5%
  • Computer Science0.9%
  • Engineering0.4%
  • Chemistry0.4%
  • その他1.9%

トピック

  • Cancer Immunotherapy and Biomarkers7.1%
  • Cancer Genomics and Diagnostics5.6%
  • Lung Cancer Treatments and Mutations5.5%
  • RNA modifications and cancer2.8%
  • Immunotherapy and Immune Responses2.7%
  • Epigenetics and DNA Methylation2.6%
  • その他73.7%

共著者

全論文

検索で開く
  1. Comprehensive molecular profiling of lung adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rameen Beroukhim, Juok Cho, Daniel DiCara, David Heiman, Pei Lin, William Mallard, Douglas Voet, Hailei Zhang, Lihua Zou, Michael S. Noble, Nils Gehlenborg, Helga Thorvaldsdottir, Marc-Danie Nazaire, Jim Robinson, William Lee, Marc Ladanyi, Nikolaus Schultz, Ronglai Shen, William D. Travis, B. Arman Aksoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Venkatraman E. Seshan, Boris Reva, Rileen Sinha, S. Onur Sumer, Nils Weinhold, Chris Sander, Natasha Rekhtman, Maureen Zakowski, Valerie W. Rusch, David G. Beer, Leslie Cope, Ludmila Danilova, James G. Herman, Stephen B. Baylin, Peter Illei, Edward Gabrielson, James Shin, Beverly Lee, Kristen Rodgers, Dante Trusty, Malcolm V. Brock, Chad J. Creighton, David Wheeler, Li Ding, Ramaswamy Govindan, Cyriac Kandoth, Robert Fulton, Lucinda L. Fulton, Michael D. McLellan, Richard K. Wilson, Kai Ye, Catrina C. Fronick, Christopher A. Maher, Christopher A. Miller, Michael C. Wendl, Christopher Cabanski, Elaine Mardis, Mark A. Watson, Sandra McDonald, Bryan Meyers, Raju Kucherlapati, Angela Hadjipanayis, Eran Hodis, Semin Lee, Angeliki Pantazi, Xiaojia Ren ほか 210 名 - Nature 2014 被引用: 5,918

  2. Mutational heterogeneity in cancer and the search for new cancer-associated genes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pei Lin, Lee Lichtenstein, David I. Heiman, Timothy R. Fennell, Marcin Imieliński, Bryan Hernandez, Eran Hodis, Sylvan C. Baca, Austin Dulak, Jens G. Lohr, Dan-Avi Landau, Catherine J. Wu, Jorge Meléndez-Zajgla, Alfredo Hidalgo‐Miranda, Amnon Koren, Steven A. McCarroll, Jaume Mora, Ryan S. Lee, Brian D. Crompton, Robert C. Onofrio, Melissa Parkin, Wendy Winckler, Kristin Ardlie, Stacey Gabriel, Charles W.M. Roberts, Jaclyn A. Biegel, Kimberly Stegmaier, Adam J. Bass, Levi A. Garraway, Matthew Meyerson, Todd R. Golub, Dmitry A. Gordenin, Shamil Sunyaev, Eric S. Lander, Gad Getz - Nature 2013 被引用: 5,755

  3. Comprehensive genomic characterization of squamous cell lung cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel DiCara, Spring Yingchun Liu, Lihua Zou, Pei Lin, Juok Cho, Marc-Danie Nazaire, Jim Robinson, Helga Thorvaldsdottir, Jill Mesirov, Chang-Jiun Wu, Bruce Johnson, David Kwiatkowski, Bruce E. Johnson, Carrie Sougnez, Stacey Gabriel, Robert C. Onofrio, Kristin Ardlie, Andy Chu, Hye-Jung E. Chun, Andrew J. Mungall, Erin Pleasance, A. Gordon Robertson, Payal Sipahimalani, Dominik Stoll, Miruna Balasundaram, Inanc Birol, Yaron S. N. Butterfield, Eric Chuah, Robin J. N. Coope, Richard Corbett, Noreen Dhalla, Ranabir Guin, An He, Carrie Hirst, Martin Hirst, Robert A. Holt, Darlene Lee, Haiyan I. Li, Michael Mayo, Richard A. Moore, Karen Mungall, Ka Ming Nip, Jacqueline E. Schein, Jared R. Slobodan, Angela Tam, Nina Thiessen, Richard Varhol, Thomas Zeng, Yongjun Zhao, Steven J. M. Jones, Marco A. Marra, Elizabeth Chun, Andy Mungall, Gordon Robertson, Adam Olshen, Alexei Protopopov, Jianhua Zhang, Xiaojia Ren, Jinhua Zhang, Jianjua John Zhang, Angela Hadjipanayis, Peng-Chieh Chen, Raju Kucherlapati, Psalm Haseley, Eunjung Lee, Peter J. Park, Semin Lee, Ruibin Xi, Lixing Yang, Nicholas D. Socci ほか 239 名 - Nature 2012 被引用: 4,052

  4. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 被引用: 1,570

  5. Non-small-cell lung cancers: a heterogeneous set of diseases

    著者: , , , , - Nature reviews. Cancer 2014 被引用: 2,023

  6. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 被引用: 1,234

  7. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Glenn Dranoff, Peter S. Hammerman, Kwok‐Kin Wong - Cancer Research 2016 被引用: 630

  8. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristin Thompson, Wendy Winckler, David J. Kwiatkowski, Bruce E. Johnson, Pasi A. Jänne, Vincent A. Miller, William Pao, William D. Travis, Harvey I. Pass, Stacey Gabriel, Eric S. Lander, Roman K. Thomas, Levi A. Garraway, Gad Getz, Matthew Meyerson - Cell 2012 被引用: 1,840

  9. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 被引用: 1,242

  10. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 688

  11. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliezer M. Van Allen - Nature Genetics 2018 被引用: 696

  12. LKB1 loss links serine metabolism to DNA methylation and tumorigenesis

    著者: , , , , , , , , , , , , , , , , , , - Nature 2016 被引用: 359

  13. In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2019 被引用: 208

  14. Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 165

  15. Fuel feeds function: energy metabolism and the T-cell response

    著者: , , - Nature reviews. Immunology 2005 被引用: 854

  16. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma

    著者: , , , , , , , , , , , , , , , - Immunity 2017 被引用: 485

  17. Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2014 被引用: 658

  18. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cancer Research 2017 被引用: 218

  19. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles M. Rudin, Nathanael S. Gray, Peter S. Hammerman, Michele Pagano, John V. Heymach, Charles M. Perou, Nabeel Bardeesy, Kwok‐Kin Wong - Nature Cancer 2021 被引用: 140

  20. Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2017 被引用: 196

  21. CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vladislav O. Sviderskiy, Max M. Quinn, Jack F. Donaghue, Eric S. Wang, Tinghu Zhang, Zhixiang He, Vamsidhar Velcheti, Peter S. Hammerman, Gordon J. Freeman, Richard Bonneau, William G. Kaelin, Kate D. Sutherland, Ariena Kersbergen, Andrew J. Aguirre, Guo‐Cheng Yuan, Eli Rothenberg, George Miller, Nathanael S. Gray, Kwok‐Kin Wong - Cancer Cell 2019 被引用: 224

  22. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Oncogene 2019 被引用: 213

  23. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

    著者: , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2019 被引用: 155

  24. LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 88